Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haynes

Showing results (371-380 of 843) with videos related to

Pageof 85
Sort By:
Journal of Proteome Research|March 12, 2008
Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibilityEden P Go, Janet Irungu, Ying Zhang, et al.
Journal of Virology|December 16, 1998
Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodiesH M Vu, D Myers, R de Lorimier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptidesT J Palker, M E Clark, A J Langlois, et al.
AIDS and Behavior|February 4, 2016
Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of SubgroupsLauren Gooden, Lisa R Metsch, Margaret R Pereyra, et al.
Cell Reports|December 30, 2015
Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding SiteAaron G Schmidt, Khoi T Do, Kevin R McCarthy, et al.
The Journal of Clinical Investigation|June 26, 2020
Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodiesMarina Tuyishime, Carolina Garrido, Shalini Jha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
Immunologic characterization of CD7-deficient miceD M Lee, H F Staats, J S Sundy, et al.
Science Translational Medicine|October 20, 2020
Prospects for a safe COVID-19 vaccineBarton F Haynes, Lawrence Corey, Prabhavathi Fernandes, et al.
Plos One|October 7, 2009
Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external regionLaurent Verkoczy, M Anthony Moody, T Matt Holl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturationB F Haynes, E A Harden, M J Telen, et al.
Pageof 85

Showing results (371-380 of 843) with videos related to

Sort By:
Pageof 85
Journal of Proteome Research|March 12, 2008
Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibilityEden P Go, Janet Irungu, Ying Zhang, et al.
Journal of Virology|December 16, 1998
Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodiesH M Vu, D Myers, R de Lorimier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptidesT J Palker, M E Clark, A J Langlois, et al.
AIDS and Behavior|February 4, 2016
Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of SubgroupsLauren Gooden, Lisa R Metsch, Margaret R Pereyra, et al.
Cell Reports|December 30, 2015
Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding SiteAaron G Schmidt, Khoi T Do, Kevin R McCarthy, et al.
The Journal of Clinical Investigation|June 26, 2020
Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodiesMarina Tuyishime, Carolina Garrido, Shalini Jha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
Immunologic characterization of CD7-deficient miceD M Lee, H F Staats, J S Sundy, et al.
Science Translational Medicine|October 20, 2020
Prospects for a safe COVID-19 vaccineBarton F Haynes, Lawrence Corey, Prabhavathi Fernandes, et al.
Plos One|October 7, 2009
Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external regionLaurent Verkoczy, M Anthony Moody, T Matt Holl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturationB F Haynes, E A Harden, M J Telen, et al.
Pageof 85